Depixus raises €30.6 million in Series A Financing
LONDON, UK: Arix Bioscience’s portfolio company Depixus has successfully completed its oversubscribed Series A financing which raised €30.6 million (£26.1 million). Depixus is a biotechnology company developing a unique technology for the fast, accurate, and straightforward extraction of multiomic information…